Open AccessSystemic therapies for metastatic renal cell carcinoma in the second-line setting: A systematic review and network meta-analysis
Author(s) -
Yang Liao,
Haifeng Hou,
Zhenhua Han,
Ying Li
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030333
Subject(s) - medicine , lenvatinib , everolimus , nivolumab , cabozantinib , oncology , renal cell carcinoma , adverse effect , meta analysis , cochrane library , cancer , sorafenib , immunotherapy , hepatocellular carcinoma